Pending further studies, activation of β2-AR represents a promising neuroprotective approach to modulate microglial phenotype, restore synaptic plasticity and treat sepsis-induced hippocampus-dependent cognitive impairments. This evidence concerns the gene ADRB2 and Cognitive impairment.